CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner2 Banner4 Banner3
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
New drug shows promise against anemia of inflammation
09-12-2014
Triptolide nanoformulation targets liver cancer cells
09-03-2014
Even if you build a toilet, they may not come - water expert
09-03-2014
New index helps predict course of early HCV cirrhosis
09-03-2014
View Complete News Library
 
 
September 19-20
GALA (GI and Liver Association of the Americas) Conference
San Francisco, California
October 17-22, 2014
American College of Gastroenterology (ACG)
Philadelphia, PA
November 7-11
The Liver Meeting 2014
Boston, MA
View all Congresses
 
 
 
 
  Line  
  Featured Abstracts          
 
Vaniprevir plus peginterferon alfa-2a and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase II study
 
Safety, pharmacokinetics and pharmacodynamics of the oral Toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C
 
The pharmacokinetics of daclatasvir and asunaprevir administered in combination in studies in healthy subjects and patients infected with hepatitis c virus
 
Treatment of hepatitis C: a systematic review
 
Ending hepatitis C in the United States: the role of screening
 
Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
 
 
Efficacy of Entecavir plus Tenofovir Combination Therapy for Chronic Hepatitis B Patients with Multi-Drug Resistant Strains
 
Entecavir Is Safe and Effective in Patients Previously Treated with Adefovir, including Those with Adefovir-Resistance
 
Assessment of Bone Mineral Density in Tenofovir treated Chronic Hepatitis B patients: Can FRAX identify those at greatest risk?
 
Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination
 
Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: A randomized controlled trial
 
Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study
 
 
Disrupted small world networks in patients without overt hepatic encephalopathy: A resting state fMRI study
 
Brain oscillatory activity during sleep shows unknown dysfunctions in early encephalopathy
 
Racial Differences in the Progression to Cirrhosis and Hepatocellular Carcinoma in HCV-Infected Veterans
 
Serum autoantibody measurement for the detection of hepatocellular carcinoma
 
The combination of TACE (transcatheter arterial chemombolization) and sorafenib is well-tolerated and effective in Asian Patients with hepatocellular carcinoma: Final results of the START trial
 
Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.